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Granulosa cell apoptosis is associated with follicular atresia; but the 
cellular mechanisms that drive this process, especially its cell specificity, are 
relatively unknown. Here, we determined that cultured granulosa cells 
abundantly express K8/K18 filaments and inhibition of protein synthesis 
enhances Fas-induced apoptosis. In this context, the roles of cFLIP, ERK1/2 
and Akt are minimal but conversely, K8/K18 filaments have a prominent role 
in granulosa cell resistance to Fas-induced apoptosis. Keratin 8/18 filaments 
in granulosa cells provide a plausible mechanism to avoid Fas-induced 
apoptosis and this mechanism potentially involves the synthesis of labile 
proteins. The existence of K8/K18 filaments in granulosa cells has relevance
to follicular atresia and the selection of follicles for ovulation. These insights 
may have bearing on future therapeutic strategies to improve female fertility.
ix
INTRODUCTION
Implications of Dairy Infertility
Animal infertility is an economic concern of today’s agricultural 
industry. The modern dairy cow is now producing more milk than ever before, 
essentially doubling output from 1951 to 1996 (Butler, 1998), but this increase 
in milk production has been accompanied by an equally-striking decline in 
fertility (Butler and Smith, 1989; Lucy, 2001). To make matters worse, 
farmers are now faced with the challenge of declining cow numbers and 
agricultural land (Dobson et al., 2007). Annual milk production per cow in the 
United States is projected to reach over 14 tons in 2050 (Santos et al., 2010), 
placing greater pressure on the metabolic needs (especially the reproductive 
needs) of the animal. Expanding our understanding of fertility at the cellular 
level will benefit the cow, the dairy farmer and ultimately, the dairy industry, if 
it leads to improvement in reproductive efficiency.
Negative Energy Balance and Infertility
At calving, high-milk producing cows enter a metabolic state referred to 
as negative energy balance (NEBAL) because nutritional intake of the cow is
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unable to meet the energy requirements for milk production. The occurrence 
of NEBAL mobilizes the cows’ body reserves (i.e., fat and muscle), which 
collectively has a negative impact on body condition, health and reproductive 
function of the cow. These metabolic changes disrupt the endocrine system 
as a whole, ultimately hindering ovarian activity (Beam and Butler, 1997;
Lucy, 2001). During NEBAL, serum levels of luteinizing hormone (LH), insulin 
and insulin-like growth factor (IGF-I) are depleted, which impairs follicle 
maturation and delays ovulation (Beam and Butler, 1997; Butler, 2000; Lucy, 
2002). In addition, the metabolic by-products of NEBAL (e.g., non-essential 
fatty acids, ketones and urea) infiltrate the follicular fluid of ovarian follicles, 
adversely affecting egg (oocyte) quality (Leroy, 2004) and, thus, further 
compromising animal fertility. For the high-milk producing cow, NEBAL and a 
decline in body condition are directly associated with a higher incidence of 
delayed ovulation, reduced conception rates, and a greater occurrence of 
embryonic loss (Lucy, 2002).
The Ovary
Ovarian Structures
The ovary in females is the primary reproductive structure responsible 
for influencing reproductive cyclicity through its secretion of steroids and for 
producing gametes (oocytes) for purposes of conception and pregnancy. The 
ovary consists of two notable endocrine structures; the follicle and the corpus
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luteum. Both of these structures develop, mature and regress during the 
course of a single reproductive cycle.
The Ovarian Follicle
Within each ovarian follicle there is the female gamete, the oocyte 
(egg), which is surrounded by two other somatic cell types, the granulosa and 
the theca cells (reviewed by Aerts and Bols, 2010). Granulosa cells are 
characterized as either membrana granulosa cells, which constitute the 
majority of cells within the interior of the follicle, or the cells that surround the 
oocyte in a mature follicle, which are known as the cumulus oophorus (Figure 
1). Theca cells comprise the supportive cells surrounding the follicle, 
separated from the granulosa cells by a basement membrane. The theca 
cells can be further subdivided into theca interna and theca externa based 
upon their vascularity and relative proximity to the basement membrane of the 
follicle (Young and McNeilly, 2010) (Figure 1). In response to systemic 
luteinizing hormone (LH), theca interna cells synthesize androgens, such as 
androstenedione, derived from the precursor molecule cholesterol. Theca- 
derived androgens diffuse across the basement membrane of the follicle to 
the granulosa cells, where follicle-stimulating hormone (FSH), also secreted 
systemically, directs the conversion of androgens to estradiol (Fortune, 1994). 
This “shared synthesis” of steroids between the theca and granulosa layers of 
maturing follicles is referred to as the “two-cell theory” and was first described 











Figure 1 Representative diagram of ovarian follicle structure and morphology.
Folliculoqenesis
Anatomically, ovarian follicles are divided into four classifications 
according to relative developmental stage: primordial, primary, secondary and 
tertiary follicles (Figure 2). Primordial follicles contain a non-growing oocyte 
surrounded by squamous epithelial granulosa cells, which range from 25-50 
pm in diameter (Figure 2a). Primary follicles contain a growing oocyte 
surrounded by cuboidal granulosa cells, and range in diameter from 35-70 pm 
(Figure 2b). Secondary follicles are roughly doubled in size (70-120 pm), and 
contain multiple layers of granulosa cells (Figure 2c). Lastly, tertiary follicles 
are largest follicles (£ 5 mm in diameter) with a defined cumulus oophorus 
surrounding the mature oocyte and antral space enclosed by membrana 
granulosa and vascularized theca cells (Figure 2d-f)(Pedersen and Peters,
1968; Gougeon and Chainy, 1987; Fairetal., 1997; Myers etal., 2004;
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Kacinskis et al., 2005; Hunzicker-Dunn and Maizels, 2006; Rodgers and 
Irving-Rodgers, 2010).
Figure2 Follicle Classification, (a) primordial, (b) primary, (c) secondary, (d) early 
tertiary, (e) tertiary, and (f) late tertiary follicles. Bar = 20pm. (Myers et al., 2004)
The Corpus Luteum
Another structure characteristic of the mammalian ovary is the corpus 
luteum. The corpus luteum (CL; Latin for yellow body) is a transient 
endocrine structure responsible for the maintenance of pregnancy through its
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secretion of progesterone (Niswender et al., 1994; Niswender et al., 2000; 
Davis and Rueda, 2002). Briefly, following the process of ovulation, the 
remaining granulosa and theca cells of the recently ovulated follicle 
differentiate to form the so-called “luteal cells” comprising the CL. In some 
species, these luteal cells retain size characteristics reminiscent of their 
precursor theca and granulosa cells, but they are generally referred to as 
simply small (<20 pm) and large (20-30 pm) steroidogenic luteal cells based 
upon their relative diameter (Alilia and Hansel, 1984; McCracken et al., 1999). 
There are distinguishing physiological characteristics of the small and large 
luteal cells, though, such as progesterone synthetic capability, sensitivity to 
LH stimulation, etc., but these aspects of distinction are beyond the scope of 
the current literature review. Suffice-it-to-say that progesterone secretion by 
both types of luteal steroidogenic cells facilitates the maintenance of 
pregnancy by preparing the. uterus for implantation and preventing 
subsequent ovulations (Kasa-Vubu et al., 1992; Davis and Rueda, 2002). In 
the event that conception fails, or a pregnancy is lost mid-gestation, the CL 
promptly undergoes regression, progesterone secretion declines, and the 
resumption of follicular development and ovulation for the next reproductive 
cycle occurs.
The Estrous Cycle
In the cow, the duration of the reproductive cycle (estrous cycle) is 
typically 21 days, but may range from 17-28 days. Each estrous cycle begins 
with the onset of ovulation (d=0), followed by an extended luteal phase (days
1-17) and a brief follicular phase (days 18-21) in non-pregnant animals. 
Similar to horses and humans, cows typically ovulate only a single oocyte per 
cycle. However, the process leading to ovulation in these species is 
distinguished by successive, temporal waves of follicular development, 
defined as “follicular waves” (Ginther et al., 1989), in which groups of follicles 
grow to yield a single, mature follicle for ovulation. Typically two to three 
waves of follicular growth occur per cycle, in which each wave consists of a 
group or cohort of follicles selected to mature, or undergo atresia, during the 
wave. This process of follicular waves ultimately results in the selection of a 
single follicle for ovulation (Fortune et al., 1991; Lucy et al., 1992).
Follicular waves during the bovine estrous cycle are characterized by 
the recruitment, selection and dominance, or atresia, of ovarian follicles 
(Hogden, 1982). Recruitment and growth of the cohort of follicles within a 
wave occurs in response to follicle stimulating hormone (FSH) from the 
anterior pituitary gland (Walters and Schallenberger, 1984). Generally, one 
follicle of the cohort is ultimately selected to continue to grow and becomes 
the dominant follicle, whereas the remaining follicles of the cohort die off in a 
process referred to as follicular atresia. The onset of dominance is identified 
as the first day the dominant follicle is 1-2 mm larger than the next largest 
follicle in the cohort, and all other follicles in the cohort (subordinate follicles) 
cease growth, as determined by ultrasonographic measures (Hodgen, 1982).
The dominant follicle of the first follicular wave may ovulate, but 
typically undergoes atresia because of high systemic concentrations of
progesterone attributed to the presence of the recently formed CL. A second 
or third wave of follicular development ensues, also yielding a dominant 
follicle which eventually becomes the preovulatory follicle (Savio et al., 1988). 
Increased plasma estradiol produced by the preovulatory follicle generates a 
positive feedback loop to the anterior pituitary, triggering a robust surge of 
luteinizing hormone (LH) secretion and ovulation. Following ovulation, 
remnants of the ruptured follicle (i.e., granulosa and theca cells) undergo 
differentiation to form the corpus luteum (CL). In the absence of fertilization, 
the CL persists for only 16-17 days after ovulation, undergoes regression 
(luteolysis), which then triggers the onset of the next estrous cycle.
As described above, dairy cows typically have two to three follicular 
waves per estrous cycle (Rajakoski, 1960; Ireland and Roche, 1983) 
Conversely, the loss of follicles (follicular atresia), the absence of ovulation, 
and premature regression of the CL are all issues contributing to infertility in 
dairy cows. For purposes of this review, we will focus only on those 
mechanisms directly pertaining to follicular atresia.
Follicular Atresia and Apoptosis
Throughout the lifespan of most female mammals, over 99% of ovarian 
follicles are lost by degenerative and hormonally controlled processes 
collectively called follicular atresia (Erickson, 1966). Tilly and Hughes (1991) 
were among the first investigators to propose apoptosis (programmed cell 
death) of granulosa cells as a direct cellular mechanism contributing to
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follicular atresia (Hughes et al., 1991; Tilly et al., 1991). Programmed cell 
death is specific, but the external factors controlling this specificity are 
relatively unknown. It is generally accepted that crosstalk within cells 
between cellular survival and death signals determine the fate of ovarian 
follicles (Amsterdam et al., 2003). However, these survival and death signals 
can be induced by a variety of external endocrine, paracrine, and autocrine 
factors, or any combination of the three (Amsterdam et al., 1999). Here we 
provide a general overview of the survival signals and death signals that 
affect granulosa cell fate within follicles, and some of the factors that influence 
these signals.
Survival Signals
The growth of follicles, or folliculogenesis, depends upon hormonal 
signals from the anterior pituitary to direct theca and granulosa cell growth 
while inhibiting apoptosis (Quirk et al., 2004). The gonadotropins, LH and 
FSH, are required at the antral stage of folliculogenesis to direct selection of 
tertiary follicles. During this time, one follicle of the cohort establishes its 
presence and becomes dominant, while subordinate follicles undergo atresia 
(Webb et al., 2007). One aspect influencing selection of the dominant follicle 
is the fact that FSH stimulates estradiol production by granulosa cells within 
this follicle, establishing its further growth and dominance (reviewed by 
Matsuda et al., 2012). For their part, the granulosa cells of selected follicles 
also secrete survival signals that promote growth (Matsuda et al., 2012). 
These signals include insulin-growth factor I (IGF-I) (Hirshfield, 1991; Webb et
al., 2007). IGF-I promotes mitosis of granulosa cells, estradiol production and 
responsiveness to further FSH and LH stimulation by increasing gonadotropin 
receptor expression (Guthrie et al., 1998; Quirk et al., 2004). Paracrine and 
autocrine effects of estradiol seceretion by granulosa cells, in concert with 
IGF-I secretion, further enhance mitosis and differentiation of granulosa cells, 
while preventing apoptosis (Quirk et al., 2004; reviewed by Palter, 2011). In 
subordinate follicles undergoing atresia these survival signals diminish, the 
granulosa cells lose functionality, and ultimately undergo apoptosis. A loss of 
estradiol and IGF-I secretion in genetic knockout mice, for instance, triggers 
granulosa cell apoptosis, abnormal follicular development, and infertility 
(Baker etal., 1996; Britt et al., 2000; Dupont etal., 2000; Zhou et al., 1997). 
Other factors influencing granulosa cell fate include epidermal growth factor 
(EGF), basic fibroblast growth factor (bFGF), interleukin-6 (IL-6) and IL-13 
(Chun etal., 1995; Guthrie etal., 1998; Lynch et al., 2000; Tilly etal., 1992), 
which stimulate granulosa cell growth and proliferation, enhance 
folliculogenesis, and promote follicle selection and dominance.
Death Signals (Apoptosis)
Apoptosis is a biological process responsible for controlling cell 
numbers and tissue size, while concurrently providing protection from 
invasive cells (Tschopp et al., 1998; reviewed by Hengartner, 2000; Peter, 
2004). The term “apoptosis” was first coined by John Foxton Ross Kerr in the 
1970’s who defined the process as consisting of two stages: 1) the formation
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of apoptotic bodies, and 2) the phagocytosis of apoptotic bodies (Kerr et al., 
1972).
All cells are equipped with the machinery to trigger apoptosis but most 
often the process is avoided by the actions of survival signals (Alberts et al., 
2002; Kanamaru et al., 2012; Peter and Krammer, 1998). Apoptosis is 
principally executed by a class of intracellular cysteine proteases known as 
caspases, which become activated by a variety of intracellular (intrinsic 
pathway) or extracellular (extrinsic pathway) influences (Fernandes-Alnemri 
et al., 1995). All caspases are initially translated as inactive proteins 
containing a pro-domain (zymogens). Most caspases are commonly 
activated by: 1) other nearby caspases (caspase-8) or 2) autocatalytic 
cleavage by another active caspase (caspase cascade; caspase-3, -6 and -7) 
(Thornberry et al., 1997; Hengartner, 2000). Active caspases are proteolytic 
and cleave proteins having aspartate residues, inhibiting their biological 
function (Hengartner, 2000).
Intrinsic Pathway
The intrinsic (mitochondrial) apoptotic pathway integrates pro-apoptotic 
and anti-apoptotic signals within the target cell by apoptotic regulator proteins 
of the bcl-2 family (Quirk et al., 2004). The bcl-2 family includes pro-apoptotic 
proteins (Bax, Bad, Bim, Bid, Bok, Bcl-2-short) and anti-apoptotic proteins 
(Bcl-2, Bcl-2-long, Bcl-w) (Antonsson and Martinou, 2000; Quirk et al., 2004). 
In response to an insult or stress, the intrinsic mitochondrial pathway
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becomes activated, releasing cytochrome c into the cytoplasm. Cytochrome 
c, apoptosis-activating factor (Apaf)-1 and pro-caspase 9 form an 
apoptosome complex (Li et al., 1997). This complex cleaves pro-caspase-9 
to its activate form, which then activates caspase-3 and other downstream 
caspases (Hengartner, 2000). Other mitochondrial pro-apoptotic proteins 
include Smac-diablo and apoptosis inducing factor (AIF) (Susin et al., 19992; 
Du et al., 2000; Verhagen et al., 2000).
Extrinsic Pathway
Signaling molecules responsible for inducing apoptosis via the extrinsic 
pathway are mediated by transmembrane death receptors (Barnhart et al., 
2003; Thornburn, 2004). Several types of cytokines induce the extrinsic 
pathway in a variety of cells (e.g., Fas ligand, tumor necrosis factor, TRAIL, 
etc.), but for purposes of the current discussion about granulosa cells, we will 
focus only on the Fas ligand-Fas-mediated pathway. The Fas receptor is a 
42-52 kDa member of the tumor necrosis factor (TNF) super family and is 
thought to trigger the apoptotic death of granulosa cells during follicular 
atresia (Matsuda-Minehata et al., 2006; Porter et al., 2000; Vickers et al.,
2000).
The Fas-induced apoptotic pathway is characterized by the expression 
of the cytokine, Fas ligand (FasL; CD95), which binds to Fas receptor, 
causing trimerization of the ligand-receptor complex. Within the target cell, an 
adaptor protein known as the Fas-Associated Death Domain (FADD) protein
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binds to the cytoplasmic region of the Fas receptor, specifically the “death 
domain” region of Fas. This interaction between Fas and FADD results in the 
binding of pro-caspase 8, forming the Death-Inducing Signaling Complex 
(DISC). Formation of the DISC results in cleavage of pro-caspase 8 to 
activated caspase 8, initiating a signaling cascade that leads to apoptosis of 
the cell (Thornburn, 2004).
Counteracting the effects of pro-caspase-8 activation and the 
downstream stimulation of apoptotic mechanisms is the molecule known as 
cellular flice inhibitory protein (cFLIP) (Hu etal., 1997). Originally discovered 
as a viral apoptotic inhibitor (Thome et al., 1997), cFLIP is a labile, anti- 
apoptotic protein that competes with procaspase-8 for binding to FADD and 
the formation of the DISC. The structure of cFLIP is identical to pro-caspase- 
8 but it lacks the enzymatic region to trigger downstream death effects 
(Micheau, 2003; Oztiirk et al., 2012). The structural similarities between 
cFLIP and pro-caspase-8 enable cFLIP to competitively bind to FADD, 
preventing pro-caspase-8 binding, and thus inhibiting pro-caspase-8 
cleavage, activation and downstream apoptotic signaling.
Survival Signaling Pathways
Growth of ovarian follicles depends upon survival signaling pathways 
within granulosa cells to override potential death signals and prevent the 
occurrence of apoptosis. Two survival pathways of particular interest in
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granulosa cells include the Ras/mitogen-activated protein kinase (MAPK) and 
the phosphoinositide 3'-OH kinase (PI3K)/Akt pathways.
The MAPK/ERK Pathway
The MAPK pathway contributes to cell survival, proliferation, and 
differentiation of granulosa cells (Chang and Karin, 2001; Pearson et al.,
2001). Mammalian MAPK are divided into four classes- the extracellular- 
signal regulated kinases (ERK1/2), Jun amino-terminal kinases (JNK1/2/3), 
p38 proteins and ERK5 (Peter and Dhanasekaran, 2003; Shiota et al., 2003). 
ERK1/2 and ERK5 are survival kinases (Nishimoto and Nishida, 2006), 
whereas p38 and JNK are implicated as apoptotic kinases (Fey et al., 2012).
The MAPK pathways are activated in response to extracellular stimuli; 
the ERK pathways are activated by growth factors, while the JNK and p38 
pathways are activated by cytokines and cellular stress (Ip and Davis, 1998). 
All of these signaling cascades involve activation of intracellular MAP kinase 
kinases that then phosphorylate either the MAP kinases ERK1/2, JNK, p38 or 
ERK5. Phosphorylated MAPK act as second messengers and translocate to 
the nucleus where they regulate gene expression of survival and apoptotic 
proteins (Zeng et al., 2005). Ultimately, the fate of the cell is determined by 
the balance between survival and apoptotic signals; i.e. if survival signals 
outweigh apoptotic signals, cell survival prevails (Nagata, 1997; Jarpe et al., 
1998).
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An illustration of this delicate balance between survival and apoptosis 
is seen in porcine granulosa cells, wherein treatment with growth factors, 
such as FSH or fetal bovine serum (FBS), actually results in apoptosis if the 
phosphorylation of ERK1/2 (a survival signal) is inhibited (Shiota et al., 2003). 
Conversely, inhibition of the p38 pro-apoptotic pathway prevents peroxide- 
induced apoptosis in this same model (Shiota et al., 2003). Phosphorylation 
of JNK prompts apoptosis of granulosa cells, implicating JNK signaling in 
follicular atresia (Peter and Dhanasekaran, 2003). ERK5 enhances 
progesterone secretion by granulosa cells, but the effect of ERK5 
phosphorylation on granulosa cell fate is not known (Gao et al., 2011).
Overall, ERK1/2 phosphorylation generally prevents apoptosis of granulosa 
cells, but phosphorylation of JNK and p38 promote apoptosis and possibly 
contribute to follicular atresia.
The PI3K/Akt Pathway
The serine/threonine kinase Akt (also known as protein kinase B; PKB) 
was originally discovered as v-Akt, a retrovirus-associated oncogene from the 
AKT8 murine retrovirus (Staal, 1977). The molecule Akt is a key player in 
cell survival, metabolism, motility and gene expression associated with the 
PI3K pathway (Cantley, 2002). This pathway is activated in response to: 1) 
phosphorylation of receptor tyrosine kinases (RTKs) by growth factors, 2) 
stimulation of G-coupled receptors, and 3) activation of integrins (Fayard et 
al., 2005). Ligand-receptor interaction results in the activation of second 
messenger PI3K by phosphorylation. Phosphorylation of PI3K can also be
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achieved by interacting with the protein Ras, which is also associated with the 
MAPK pathway (Datta et al., 1999). The activation of PI3Ks further stimulate 
second messenger phosphoinosotides by phosphorylation (i.e. converting 
phosphatidylinosotide-4-5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5- 
triphosphate (PIP3) (Rameh and Cantley, 1999). The formation of PIP3 then 
facilitates recruitment of Akt to the plasma membrane and activates it by 
phosphorylation (Fayard et al., 2005).
This pathway and its interaction with the MAPK pathway are relevant 
to the fate of granulosa cells and follicular development because within 
bovine ovaries, levels of Akt, phosphorylated Akt (p-Akt), ERK and 
phosphorylated ERK (p-ERK) are all elevated in dominant follicles compared 
to subordinate follicles (Ryan et al., 2007). In addition, inhibition of the PI3K 
pathway impairs granulosa cell responsiveness to FSH and IGF stimulation 
(Ryan et al., 2008). This suggests both the MAPK and PI3K pathways have a 
critical role in the fate of granulosa cells within the follicle, and most likely 
influence the selection of dominant versus subordinate follicles during 
folliculogenesis.
Fas and the Follicle
A physiologic mechanism of atresia in follicles is the effect of Fas- 
induced apoptosis of granulosa cells (Hughes et al., 1991; Tilly et al., 1991). 
Both Fas and FasL are expressed in ovaries of mammals across most 
species, including humans, domesticated livestock and rodents (Dharma et
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al., 2003; Inoue et al., 2006; Kim et al., 1998; Quirk et al., 1995; Quirk et al., 
1998; Vickers et al., 2000). Differential expression of FasL and/or Fas among 
granulosa cells of follicles might influence the occurrence of apoptosis and 
follicular atresia.
In granulosa cells, Fas expression increases following pretreatment 
with the cytokines interferon gamma (IFNy) and tumor necrosis factor alpha 
(TNFa), causing the cells to be vulnerable to Fas-induced apoptosis (Quirk et 
al., 1998; Porter et al., 2000; Vickers et al., 2000). Inhibition of protein 
synthesis (via cycloheximide) also enhances granulosa cell sensitivity to Fas- 
induced apoptosis (Quirk et al., 1995; Quirk et al., 1998), implying that labile, 
anti-apoptotic proteins exist within granulosa cells to prevent apoptosis.
The expression of Fas has been evaluated in bovine follicles across 
the estrous cycle; expression of Fas mRNA is highest in granulosa cells of 
atretic, subordinate follicles and lowest in preovulatory follicles (Porter et al., 
2000). This suggests one aspect of follicular atresia is the upregulation of 
Fas mRNA in granulosa cells. However, it is noteworthy that granulosa cells 
of these same atretic follicles in vitro are generally resistant to Fas-induced 
apoptosis unless pretreated with cytokines such as IFNy or TNFa (Quirk et 
al., 1998; Porter et al., 2001). Additional factors must exist either within the 
granulosa cells, or within their follicular environment (i.e., in vivo) to affect 
sensitivity to Fas-induced apoptosis.
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Mechanisms that influence Fas expression
In vitro versus in vivo environment could have profound effects on the 
expression of the Fas receptor by granulosa cells. Fas expression and 
trimerization in response to FasL are both necessary for induction of the Fas- 
induced apoptotic pathway, but it is currently unclear what cellular 
mechanisms regulate Fas expression on the surface of granulosa cells. In 
liver epithelial cells (hepatocytes), cytoskeletal intermediate filaments 
influence Fas expression and Fas-induced cell signaling (Coulombe and 
Omary, 2002). Genetic knockout of the intermediate filament protein, keratin 
8 (K8), increases Fas expression and enhances the sensitivity of hepatocytes 
to Fas-induced apoptosis (Gilbert et al., 2001). Similarly, our laboratory has 
* determined that the absence of keratin 18 (K18) -containing intermediate 
filaments makes HeLa cells more sensitve to Fas-induced apoptosis (Sullivan 
et al., 2010). Interestingly, hepatocytes of K8-null mice also express less 
ERK1/2 and cFLIP compared to hepatocytes of wild-type mice, suggesting 
the expression of keratin intermediate filaments, the presence of cFLIP and 
the activation of ERK1/2 may together protect the cells from Fas-induced 
apoptosis (Gilbert et al., 2004).
Keratin Intermediate Filaments
Intermediate filaments (IFs) were first described by Ishikawa et al. in 
1968 as cytoskeletal scaffolds in the nucleus and cytoplasm in metazoans 
(Ishikawa et al., 1968; Kim et al., 2007). Together with microtubules and
18
microfilaments, IFs comprise the third component of the cytoskeleton of most 
cells. Structurally, all IFs are comprised of a central helical rod flanked by N- 
terminal and C-terminal head and tail domains, respectively; the rod domains 
are conserved among subclasses, but terminal domains are conserved 
across all IFs (Figure 3) (Fuchs and Weber, 1994).
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Figure 3 Tripartite structure of intermediate filaments (Coulom be and O m ary 2002).
The generally understood function of IFs is to provide structural integrity, but 
in recent years a more dynamic role for these structures has been suggested, 
including the modulation of apoptosis, responsiveness to physiologic stress, 
wound healing, facilitating cell growth and mitosis, regulating tissue polarity 
and influencing tissue remodeling (Moll et al., 2008).
The keratins are a subclass of IFs occurring as heterodimers 
composed of a type I (acidic; numbered 9-20) and type II (basic; numbered 1- 
8) filament. Keratin 8/18 (K8/K18) IFs are considered characteristic of simple 
epithelia (including granulosa and theca cells of follicles), immortalized cell
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lines and carcinomas; and they are the first keratin proteins expressed during 
embryonic development (Moll et al., 1982; Jackson et al., 1980).
In recent years, investigators have discovered many novel functions for 
keratin IFs beyond their well-accepted role in providing structural support to 
the cell. For instance, there is current thinking that K8/K18 IFs sequester the 
activity of intracellular kinases, especially following cellular stress. Essentially 
the filaments provide an abundance of serine residues within their structure, 
serving as phosphorylation substrates or “phosphate sponges” for stress- 
activated kinases (e.g., Akt). This action prevents the activation of 
downstream pathways by these stress kinases that might otherwise lead to 
apoptosis (Ku and Omary, 2006). The solubilization and polymerization 
activities of the keratins are directly influenced by this serine phosphorylation 
in the head and tail domains of K8 (Ser-23/Ser-73/Ser-431) and K18 (Ser- 
33/Ser-52) (Omary et al., 1998; Coulombe and Omary 2002; Owens and 
Lane, 2003; Omary et al., 2006). In this manner, the sheer abundance of the 
filaments with their multiple phosphorylation sites re-direct the activities of 
apoptotic kinases away from downstream death-signaling mechanisms (Ku 
and Omary, 2001). Interestingly, K8 and K18 also have phosphorylation sites 
that are recognized by MAPK (Galarneau et al., 2006) and cell cycle 
progression 14-3-3 proteins (Liao and Omary, 1996) The Ser74 and Ser431 
phosphorylation sites on K8 are associated with ERK1/2 (Ku and Omary, 
1997) and p38 (Ku et al., 2002). Liao and Omary demonstrated that K8/K18 
hyperphosphorylation during the S and G2/M phases of the cell cycle result in
20
14-3-3 protein binding, that in turn, activate PI3K and MAPK pathways (Liao 
and Omary, 1997). Thus K8/K18 IFs within cells may activate cell 
proliferation pathways in response to stress signals as a protective 
mechanism.
Beyond these measures, K8/K18 filaments protect cells from 
apoptosis, stress and injury by impairing the cell surface expression of Fas 
and the downstream activation of caspases (Gilbert et al., 2001). Inhibition of 
caspase activation occurs, in part, by enhancing the expression and 
activation of the anti-apoptotic proteins cFLIP and ERK1/2 (Gilbert et al., 
2004). Genetic knock-down of K8 reduces endogenous c-FLIP expression 
and decreases phosphorylation of ERK1/2, making mouse hepatocytes three 
to four times more sensitive to FAS-induced apoptosis than their wild-type 
counterparts (Gilbert et al., 2001; Gilbert et al. 2004). Thus, K8/K18 filaments 
are thought to provide resistance to Fas-induced apoptosis by suppressing 
Fas expression and caspase activation, while concomitantly activating 
survival pathways and promoting cell proliferation.
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K8/K18 Filaments and Granulosa Cells
Keratins are expressed in granulosa cells of bovine follicles across the 
developmental stages, but their role in folliculogenesis is unknown 
(Czernobilsky et al., 1985; Gall et al., 1992; Santini et al., 1993; Townson et 
al., 2010; van den Hurk et al., 1995). The K8/K18 filaments are expressed in 
granulosa cells of the follicle, but their expression in atretic follicles is less 
evident than growing or recently ovulated follicles (Townson et al., 2010). 
Additionally, the relative expression of K8/K18 filament expression in 
granulosa cells is inversely proportional to the number of cells undergoing 
apoptosis as observed by Cyto-DEATH immunodetection (Townson et al., 
2010). This suggests the onset of apoptosis of granulosa cells and the 
occurrence of follicular atresia are associated with a loss of K8/K18 filaments. 
Others have shown Fas-induced apoptosis in granulosa cells is augmented 
by inhibition of cFLIP and inactivation of ERK1/2 (Matsuda et al., 2008; Shiota 
et al., 2003). At present, however, no one has determined whether K8/K18 
filaments modulate Fas-induced apoptosis of granulosa cells of follicles 
through cFLIP expression and/or ERK1/2 phosphorylation as has been 




The present study proposes there is a functional connection between 
K8/K18 filament expression, apoptosis-inhibition and survival signaling in 
granulosa cells influencing their vulnerability to apoptosis. The current study 
investigated the above-described relationships in the context of Fas-induced 
apoptosis and follicular atresia.
The objectives of the study were to 1) determine the relative 
expression of K8/K18 filaments in granulosa cells of human and bovine origin 
and 2) identify putative cellular mechanisms by which granulosa cells resist 
Fas-induced apoptosis, specifically determining whether or not K8/K18 
filaments have a role in this protection.
We postulated K8/K18 expression, in part, accounts for the relative 
resistance of granulosa cells to Fas-induced apoptosis by: 1) decreasing the 
cell surface expression of Fas, 2) enhancing apoptosis-inhibiting proteins, and 
3) activating intracellular pro-survival pathways.
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CHAPTER I
INVESTIGATION OF THE ROLE OF KERATIN 8/18 INTERMEDIATE 
FILAMENTS ON THE FATE OF GRANULOSA CELLS
Introduction
Infertility is an ever-growing concern of today's agricultural industry 
(Lucy, 2001). For dairy operations, profitability depends upon the ability of 
the cow to give birth to a live calf each year. Follicular atresia is one aspect 
of ovarian function that contributes to poor reproductive performance and may 
result in infertility (Lucy, 2002).
Apoptosis of granulosa cells is contributing factor to follicular atresia 
within the ovary, preventing follicle maturation and ovulation, and possibly 
impairing fertility in females (Hughes and Gorospe, 1991; Tilly et al., 1991).
24
The extrinsic pathway of apoptosis, activated by cytokines and other 
influences external to the targeted cell, is thought to contribute to the process 
of follicular atresia (Townson and Combelles, 2012). The cytokine Fas ligand 
(FasL) and its corresponding receptor, Fas, for instance, are elevated in 
atretic follicles compared to healthy follicles (Kim et al., 1998; Vickers et al., 
2000; Porter et al., 2001; Inoue et al., 2006). However, cultured granulosa 
cells are typically resistant to Fas-induced apoptosis unless first pretreated 
with tumor necrosis factor (TNF) and interferon-gamma (IFN) (Quirk et al., 
1995), which is thought to increase the surface expression of Fas (Quirk et 
al., 1998). It is therefore conceivable that Fas-induced apoptosis of granulosa 
cells contributes to follicular atresia, and that cytokines such as TNF and IFN 
facilitate this process.
The targeted and selective loss of granulosa cells by apoptosis without 
accompanying collateral damage to adjacent cells is a characteristic aspect of 
follicular atresia. Apoptosis is also a hallmark of the FasL-Fas system, by 
which the immune system establishes immune tolerance and the elimination 
of lymphocytes targeted against self-antigens. The cytokines TNF, TRAIL, 
and their corresponding receptors are additional influences, similar to FasL 
and Fas, which potentially trigger apoptosis and induce follicular atresia in 
certain species (Prange-Kiel et al., 2001; Xiao et al., 2002; Inoue et al., 2003). 
However, beyond these hormonal influences on granulosa cell viability within 
follicles, there are structural, cytoskeletal influences to consider. In the last 
decade, for instance, a number of studies have implicated the cytoskeletal
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elements (i.e., microtubules, microfilaments, and intermediate filaments) as 
profoundly affecting follicular growth, potentially impairing ovulation, and 
causing cystic follicles (Salvetti et al., 2004; Ortega et al., 2007; Salvetti et al., 
2010).
Microtubules, microfilaments, and intermediate filaments collectively 
influence the activities of most cells, including the granulosa cells within 
follicles. Microtubules regulate steroidogenesis (Chen et al., 1994), but they 
also determine cell shape and affect cytoplasmic movement of organelles 
within granulosa cells (Sutovsky et al., 1994). Microfilaments drive granulosa 
cells toward differentiation (i.e., luteinization) (Amsterdam and Rotmensch, 
1987) and facilitate death (Amsterdam et al., 1997). Under apoptotic 
conditions, for example, microfilaments within granulosa cells undergo 
rearrangement to compartmentalize the steroidogenic machinery to the 
perinuclear region while directing other proteolytic activities to the apoptotic 
bodies (Amsterdam et al., 1997). The intermediate filaments, including 
vimentin, the cytokeratins, and desmin, influence cell mitosis, follicular 
atresia, and de-differentiation of cells of the follicle (van den Hurk et al., 1995; 
Khan-Dawood et al., 1996; Loffler et al., 2000). Most recently, our laboratory 
has identified intermediate filaments, particularly keratin 8 and keratin 18 
(K8/K18) filaments, as possible intrinsic modulators of granulosa cell 
apoptosis during folliculogenesis (Townson et al., 2010).
The K8/K18 filaments are considered “stress filaments” characteristic 
of most simple epithelia, immortal cell lines and carcinomas. They provide
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structural integrity and mechanical stability to cells via cell-cell junctions (Moll 
et al., 2008; Waschke, 2008). Recently, dynamic features of these filaments 
have become evident, suggesting the K8/K18 filaments also modulate death 
signaling by regulating cytokine receptors, enhancing anti-apoptotic proteins 
and activating intracellular survival pathways (Gilbert et al., 2001; Marceau et 
al., 2001; Eriksson et al., 2009; Sullivan et al., 2010). Genetic knockdown of 
K8 in mouse hepatocytes, for instance, increases the cell surface expression 
of Fas and up-regulates caspase activation (Gilbert et al., 2001). The 
expression of the anti-apoptotic protein cellular flice inhibitory protein (cFLIP; 
also known as CFLAR) and the phosphorylation of extracellular regulated 
kinases 1 and 2 (ERK1/2) are also impaired in these hepatocytes (Gilbert et 
al., 2004). As a result, the K8-null hepatocytes are three to four times more 
sensitive to Fas-induced apoptosis (Gilbert et al., 2001; Gilbert et al., 2004). 
The K8/K18 filaments within granulosa cells of follicles might orchestrate 
similar aspects of cellular fate, possibly enabling the cells to evade Fas- 
induced apoptosis by impairing Fas expression, augmenting cFLIP 
expression and/or ERK1/2 phosphorylation.
The objectives of the current study were to investigate the above­
described possibilities by: 1) determining the relative expression of K8/K18 
intermediate filaments within granulosa cells, 2) identifying cellular 
mechanisms by which granulosa cells resist Fas-induced apoptosis, and 3) 
determining if K8/K18 filaments have a role in this resistance. For the 
majority of this work, immortal cells established from a granulosa cell tumor,
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the KGN cell line, were utilized. The cells retain many physiological attributes 
of granulosa cells, including responsiveness to FSH through a functional FSH 
receptor (Nishi et al., 2001). Additional experiments with primary cultures of 




Animal Care and Use
Follicles from bovine ovaries were obtained from local slaughterhouse 
facilities or research cows at the Fairchild Dairy Teaching and Research 
Center. A protocol for this purpose was approved by the UNH Animal Care 
and Use Committee (IACUC) # 120104.
Cells and culture conditions
KGN cell line
The human granulosa cell tumor line, KGN, was generously provided 
by Dr. Fukuzawa (RIKEN Cell Bank, Koyadai, Japan) through our 
collaborator, John S. Davis (University of Nebraska Medical Center, Omaha, 
NE). The KGN cells were maintained in DMEM/F12 (1:1; Life Technologies, 
Grand Island, NY) supplemented with 10% FBS (JRH Biosciences, Lenexa, 
KS) at 37°C with 5% CO2 and 95% air, with 95% humidity.
Primary bovine granulosa cells
The bovine ovaries obtained from slaughterhouse facilities and the
Fairchild Dairy were transported to the laboratory at 25°C in sterile saline, and
then rinsed in ethanol, Betadine solution and PBS before dissecting all
follicles s 10 mm in DMEM/F12 + 2 pL/mL gentamicin. Follicular fluid from
each of the follicles was removed by aspiration, the follicles were bisected
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and then gently scraped to release the granulosa cells. The granulosa cells 
were washed three times for 10 minutes at 25 °C at 500, 250 and 175 x g to 
remove red blood cells. Once washed, the cells were counted using the 
Trypan Blue exclusion method then seeded in plastic cultureware and 
maintained in DMEM/F12 (1:1; Life Technologies, Grand Island, NY) 
supplemented with 10% FBS (JRH Biosciences, Lenexa, KS) at 37°C with 5% 
C02 and 95% air, with 95% humidity.
Culture conditions
The granulosa cells (KGN and bovine) were either seeded in 96-well 
plates (BD Biosciences, San Jose, CA) at 1x104 cells/well for Caspase-Glo 
3/7, CellTiter 96 and In-Cell Western assays, seeded in 6-well plates 
(Corning, Corning, NY) at 3x105 cells/well for immunoblotting experiments or 
seeded in microchamber slides (Nunc, Rochester, NY) at 1x104 cells/well and 
T75 or T150 vented flasks (BD Biosciences, San Jose, CA) at 5x105 cells and 
1x106 cells/flask, respectively, for immunofluorescence and flow cytometry 
analysis. In all cases, the granulosa cells were grown to 70% confluency 
prior to the onset of treatments. For siRNA experiments, conditioned culture 
medium was exchanged for antibiotic-free DMEM/F12 medium + 10% FBS, 
and immediately prior to cytokine treatments, exchanged for again for serum- 
free DMEM/F12 medium.
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Immunofluorescent visualization of K8/K18 intermediate filaments
Following culture, granulosa cells grown in microchamber slides were 
rinsed twice with PBS and then fixed for 20 minutes at room temperature with 
2% paraformaldehyde (PFA) in a microtubule-stabilizing buffer (100 mM 
HEPES, pH 7.31; 1 mM MgS04-7H20; 1 mM EGTA; 0.2% Triton X-100). 
Subsequently, the fixed cells were permeabilized for 20 minutes in ice-cold 
100% methanol. After permeabilization, the cells were washed three times 
with PBS + 0.1% BSA and labeled with mouse anti-human K18-FITC- 
conjugated antibody (CY90; Sigma-Aldrich, St. Louis, MO) diluted 1:100 in 
PBS + 1% BSA and Rhodamine Phalloidin (Life Technologies; Grand Island, 
NY) diluted 1:400 in PBS + 1% BSA for 1 hour at 37°C in a humidified 
chamber. In previous work, the dimerization of K18 protein with K8 protein to 
form a K8/K18 heterodimeric filament bovine granulosa cells and luteal cells 
was verified (Townson et al., 2010; Duncan et al., 2012). Thus, 
immunological targeting of K18 for the detection of K8/K18 filaments in the 
granulosa cells was considered adequate. For a negative control, the cells 
were exposed to a mouse anti- human IgG-FITC-conjugated antibody 
(Sigma-Aldrich, St. Louis, MO) diluted 1: 100 in PBS + 1% BSA as a 
substitute for the primary antibody. The slides were washed three times with 
PBS + 0.1% BSA, then mounted on coverslips with ProLong® Gold Antifade 
reagent containing DAPI (Life Technologies, Grand Island, NY).
Photographic Images of the K8/K18 filament immunostaining were collected 
using an Olympus BH2-RFC upright fluorescent microscope (Center Valley,
PA), Qimaging QICAM monochrome digital camera (Surrey, BC, Canada) 
and ImagePro Insight software (Media Cybernetics, Bethesda, MD).
Flow cytometric quantification of Fas surface and K18 expression
Cultured cells were trypsinized using Cellgro 0.25% Trypsin-EDTA
(Corning, Corning, NY) and fixed for 20 minutes at room temperature with 2%
paraformaldehyde in a microtubule-stabilizing buffer (100 mM HEPES, pH
7.31; 1 mM MgS04-7H20; 1 mM EGTA; 0.2% Triton X-100). For Fas surface
staining, the cells were stored in paraformaldehyde; for K18 staining, the cells
were fixed with paraformaldehyde, permeabilized in ice-cold 70% ethanol for
20 minutes and then stored at -20°C. For antibody labeling, both types of cell
preparations were washed three times with PBS + 0.1% BSA, and then either
labeled overnight at 4°C with mouse anti-human Fas (CH11; EMD Millipore,
Darmstadt, Germany) antibody diluted to 20 pg/mL in 10% normal goat serum
+ PBS + 1% BSA or labeled for 1 hour at 37°C with mouse anti-human K18-
FITC-conjugated antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:100 in
PBS + 1% BSA. Separate preparations labeled with mouse anti-human IgG-
FITC-conjugated antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:100 in
PBS + 1 % BSA served as negative controls. For cells labeled with Fas
antibody, the cells were subsequently washed three times with PBS + 0.1%
BSA, and then incubated for 1 hour at 37°C with Alexa Fluor® 488 (Life
Technologies, Grand Island, NY) diluted 1:200 in 10% NGS + PBS + 1%
BSA. For both Fas- and K18-labeled cells, the cells were washed three times
with PBS + 0.1% BSA and then analyzed using a 4 color, dual laser FACS
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Calibur Flow Cytometer (BD Biosciences, San Jose, CA), quantifying 10,000 
cells. Data were collected using CellQuest software (BD Biosciences; San 
Jose, CA) and then analyzed using WinMDI (Joe Trotter; Purdue University, 
West Lafayette, IN) to quantify the cell surface expression of Fas and K8/K18 
filament expression.
Induction of Fas-mediated apoptosis
Granulosa cells were cultured and exposed to pretreatments of 
cycloheximide (CHX; 0.25 pg/mL; Sigma-Aldrich, St. Louis, MO), the MEK1/2 
inhibitor PD98059 (30 pM; Cell Signaling Technologies, Danvers, MA) or the 
Akt inhibitor Wortmannin (100 nM; EMD Millipore, Darmstadt, Germany) for 2 
hours in serum-free culture medium. After pretreatment, the cells were 
exposed to a Fas-activating antibody (1 pg/mL; clone CH11; EMD Millipore, 
Darmstadt, Germany) or Staurosporine (1 pM; MP Biomedical, Santa Ana, 
CA) as a positive control, to induce apoptosis. The cells were exposed to the 
above treatments for 8 and 24 hours, at which time the incidence of apoptosis 
was measured by caspase 3/7 activity using a Caspase-Glo® 3/7 Assay or a 
cell viability Cell Titer 96 (MTS) assay. These assay were conducted 
according to the manufacturer’s instructions (Promega, Madison, Wl).
Immunoblot analysis for Fas. cFLIP. cleaved PARP and B-Actin
Nearly confluent cells from the above-described experiments were 
washed twice with ice-cold PBS and harvested in lysis buffer (10mM Tris- 
HCL; 1mM EDTA; 1mM EGTA; 100mM NaCI; 1% Triton X-100; 0.5% Nonidet
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P-40, pH 7.4) containing kinase, protease and phosphatase inhibitor cocktails 
(Sigma-Alrich, St. Louis, MO). The cells were scraped, collected, and 
sonicated for 3 seconds then resuspended in 2X SDS loading buffer (100 mM 
Tris-CI, pH 6.8 + 4% SDS, 0.2% bromophenol blue, 20% glycerol, 200 mM 
DTT) and denatured at 95°C for 5 minutes. Total cellular proteins were 
separated by 12.5% SDS-PAGE and then transferred to polyvinylidene 
difluoride (PVDF) membranes (EMD Millipore,Darmstadt, Germany). 
Immunoblotting was performed using antibodies to detect human cFLIP (also 
known as CFLAR) (rabbit anti-human CFLAR; Sigma Aldrich, St. Louis, MO) 
and human Fas (clone C-20; Santa Cruz Biotechnology, Santa Cruz, CA) to 
determine the effect of cytokine and inhibitors on expression of cFLIP and 
Fas. Membranes were stripped and reprobed for cleaved human poly ADP 
ribose polymerase (PARP) (# 9542, Cell Signaling Technology, Danvers,
MA), involved in DNA depletion and DNA repair during cell death, to validate 
apoptotic activity and P-actin (clone AC-15; Sigma Aldrich, St. Louis, MO) for 
normalization of protein loading.
Short interfering RNA (siRNA) knockdown of K8/K18
Granulosa cells were transiently transfected with 6-10 pmol KRT8 and 
KRT18 siRNA constructs according to RefSeq numbers: NM_001033610.1 
and NM_001192095.1 (siRNA ID S444557 and S444560; Silencer® Select 
siRNA, Ambion Inc., Foster City, CA). Transfection was achieved using 
Lipofectamine™ RNAiMAX in OptiMEM® Reduced Serum Media for final 60- 
100 nM RNAi duplexes according to the manufacturer’s instructions (Life
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Technoloies, Grand Island, NY). Briefly, cells were grown to 70% confluency 
then switched to antibiotic-free DMEM/12 + 10% FBS before siRNA- 
Lipofectamine duplexes were introduced. The cells were also exposed to a 
non-targeting siRNA (Silencer® Select Negative Control #1; Ambion Inc., 
Foster City, CA) and Lipofectamine™ alone as negative controls. Optimal 
siRNA and Lipofectamine concentrations were established and validated 
using an In-Cell Western assay according to the manufacturer’s instructions 
described briefly below (Cell Signaling Technology, Danvers, MA; LI-COR®, 
Lincoln, NE).
Validation of K8/K18 knockdown (In-Cell Western Assay)
After 72 hours of transfection, the siRNA duplexes were removed from 
the culture medium, the cells were washed and then fixed and permeabilized 
for 10 minutes in ice-cold 100% methanol. Following permeabilization, the 
cells were washed three times in PBS, then exposed to blocking for one hour 
at room temperature (Blocking Buffer: PBS + 5% normal goat serum + 0.3% 
Triton X-100). Subsequently, the cells were incubated overnight at 4°C with a 
primary antibody cocktail of mouse anti- human K18 (CY90; Sigma-Aldrich,
St. Louis, MO) and rabbit anti-human P-Actin (13E5, Cell Signaling 
Technolgy, Danvers, MA) diluted 1:800 and 1:200, respectively, in antibody 
dilution buffer (PBS /1%  BSA / 0.3% Triton X-100), respectively. After 
washing three times for five minutes each in PBS, the granulosa cells were 
incubated for 1 hour at room temperature in the dark with a cocktail of 
fluorochrome-conjugated secondary antibodies (goat anti-mouse IgG H+L
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DyLight 800 and goat anti- rabbit IgG H+L DyLight 680, Cell Signaling 
Technology, Danvers MA) diluted 1:2000 and 1:1000, respectively, in 
antibody dilution buffer. After washing three times for five minutes each, 
plates containing the cells were scanned on the LI-COR® Odyssey® Classic 
Infrared Imaging scanner (LI-COR, Lincoln, NE) at 680 and 800 nm in the 
infrared color spectrum. Staining intensity for K18 was normalized to staining 
intensity for p-actin using the provided scanning (LI-COR, Lincoln, NE) 
(protocol adapted from In-Cell Immunofluoresence protocol, Cell Signaling 
Technology, Danvers, MA). Expression of K18 (relative to P-actin) provided a 
method to normalize staining intensity across treatments to account for 
differences in seeding density, possibly as a result of cytotoxicity.
Statistical analysis
All experiments were repeated three to six times, using a fresh aliquot 
of cells (KGN) or bovine follicles for each experiment. Data were analyzed 
initially by one-way or two way analysis of variance (ANOVA), followed by a 
Tukey’s post-test for multiple comparisons. Differences among means at a 
value of P<0.05 were considered statistically significant.
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Results
K18 and B-Actin expressed in KGN cells
Immunofluorescence for K18 and p-actin indicated KGN cells express 
abundant K8/K18 and p-actin filaments (Figure 4).
Figure 4  Representative image of immunofluorescent staining in cultured KGN cells. (A ) 
DAPI, (B ) K18 filaments stained with F ITC  (green), (C ) P-Actin stained with Phalloidin (red) 
and (D ) merged image (200X, bars represent 20 microns).
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High K18 expression but low Fas surface expression on KGN Ceils
Flow cytometry analysis confirmed ~91% of the KGN cells express K18 
protein, yet only 24% of the cells express Fas on the cell surface (Figure 5). 
Mean fluorescent intensity measures (an indication of fluorescence per cell) 
were similarly high for K18 expression, but low for Fas expression (Fig. 5D).
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Figure 5 Representative flow cytometric analysis of K18 and surface Fas staining in cultured 
KGN cells (A ,B), Percentage of cell population K18+ and surface Fas+ (C) and mean  
fluorescence intensity (D) in KGN cells. Representative histograms and dot plots of 
fluorescence intensity vs. number of recorded events for (A ) K18 and (B) surface Fas 
expression. (C ) Percentage (% ) of KGN cell population (±SEM ) stained positively for K18 and 
surface Fas. (D ) M ean fluorescence intensity (±S EM ) o f K18 and surface Fas staining in KGN  
cells. (n=3 experiments).
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Inhibition of protein synthesis sensitizes KGN cells to Fas-induced 
apoptosis
KGN cells exposed to the protein synthesis inhibitor, CHX, prior to 
treatment with the Fas activating antibody, CH11, augmented Fas-induced 
apoptosis (Figure 6). Treatment with CH11 or CHX alone, however, had no 
effect. Inhibition of de novo protein synthesis with CHX provoked a 10-fold 
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Figure 6 Fas-mediated apoptosis in cultured KGN cells, quantified by caspase 3 /7  activity 
(RLU; ±SEM ) following protein synthesis inhibition. The cultures were exposed to protein 
synthesis inhibitor C H X  (0.25 pg/mL) for 10 hours and Fas (1 pg/mL activating antibody 
C H 1 1) for a  period of 8 hours (n=6 experiments; different letters denote differences, p< 0 .05).
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Fas and cFLIP expression following Fas-induced apoptosis of KGN cells
No overt changes in the expression of Fas or cFLIP protein were 
observed following exposure of cultured KGN cells to CHX or CH11 (Fas 
activating antibody) (Figure 7 A). Conversely, Fas-induced apoptosis by these 
treatments was confirmed by detection of PARP and cleaved PARP (Figures 
7A &B). Confirming the Caspase-Glo 3/7 assay results above, the combined 
treatment of CHX+CH11 caused a 2-fold increase in cleaved PARP 
compared to the control cultures.
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Figure 7 Immunodetection of Fas, cFLIP, cleaved PAR P and p-Actin following exposure to the 
protein synthesis inhibitor C HX (0.25 pg/mL) and Fas stimulation (1 pg/niL activating antibody 
C H11) in KGN cells. A . Representative immunodetection of Fas, cFLIP, cleaved PAR P and P- 
Actin following treatments. B. Average expression of Fas, cFLIP and cleaved PA R P (±S E M ) 
relative to p-Actin following treatment (n=3 experiments, different letters denote differences, 
p<0.05).
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Inhibition of ERK1/2 and Akt fails to sensitize KGN cells to Fas-induced
apoptosis
Inhibition of the MAPK pathway had no effect on Fas-induced 
apoptosis (Figure 8). Conversely, inhibition of the PI3K pathway provided 


















F igure 8  Induction of Fas-mediated apoptosis in cultured KGN cells, quantified by 
caspase 3/7 activity (RLU; ±S EM ) following ERK 1/2 inhibition. The cultured cells were  
exposed to ERK1/2 inhibitor P D 98059 (30 pM) and C H X  for 10 hours and Fas 
activating antibody for 8 hours (n=3 experiments; different letters denote differences, 
P<0.05).
□  Without Wortmannin
■  With Wortmannin
Control CHX + Fas Staurosporine
Figure 9 Induction of Fas-mediated apoptosis in cultured KGN cells, quantified by 
metabolic activity (M TS  assay; ±S EM ). The cultured cells w ere exposed to Akt inhibitor 
Wortmannin (100 nM) and C H X  for 26  hours and Fas activating antibody for 24  hours 
(n=3 experiments; different letters denote differences among treatments, apostrophes 
denote differences between without and with Wortmannin within treatment groups; 
P<0.05).
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Genetic downrequlation of K8/K18 filaments (siRNA) enhances Fas- 
induced apoptosis of granulosa cells
For the KGN cells, optimized treatment conditions after 72 hours of 
transfection were 10 pmol KRT8 and KRT18 siRNA combined with 0.3 pL 
Lipofectamine RNAiMAX (100 nM siRNA duplex) (Figure 10A), which resulted 
in 30% downregulation of K18 expression compared negative controls (Figure 
10B). For primary cultures of bovine granulosa cells, optimal transfection 
conditions consisted of 6 pmol KRT18 siRNA combined with 0.3 pL 
Lipofectamine RNAiMAx (60 nM siRNA duplex), which reduced K18 
expression by 65% expression (Figure 10B).
Bovine 
Granulosa cells
10 pmol KRT8 + 
KRT18 SiRNA




6 pmol KRT18 SiRNA




1.2 ■  KGN 
□  Bovine GC
Negative Control Negative Control siRNA KRT8/13 siRNA
Figure 10 Immunodetection of K18 expression in granulosa cells mock transfected or 
transfected with 100 nM (KGN cells) or 60  nM (bovine granulosa cells) siR N A  to K RT8  
and18. A. Representative In-Cell W estern dual detection of K18 protein (green) and (3-Actin 
protein (red) following K R T8/18 siRNA. Negative controls consisted of cells transfected with 
equimolar concentrations of a non-targeting siRNA or Lipofectamine™ alone B. 
Quantification of K18 relative to (3-actin expression following K RT8/18-siR NA  transfection. 
Apostrophes denotes differences within cell types (P<0.05; KGN, n=3 experiments; bGC, n=1 
experiment).
42
Genetic knock-down of the K8/K18 filaments with siRNA enhanced 
Fas-induced apoptosis compared to negative control (i.e. scrambler siRNA) in 










□  Without Fas 
■ With Fas
Negative Control siRNA KRT8/18 siRNA
F igure 11 Induction of Fas-mediated apoptosis measured by caspase 3 /7  activity (RLU; 
±SEM ) following siRNA transfection with a negative control siRNA and K RT8 and 18 siRNA  
in cultured KGN cells (n=3 experiments; different letters denote differences, P< 0 .05).
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Discussion
During follicular atresia, discrete populations of granulosa cells within 
the follicle undergo apoptosis. However, the mechanisms regulating the cell- 
specificity of this process are unclear (Tilly et al., 1991). Previously, we 
suggested the prevalence and the cell-specificity of K8/K18 filaments within 
the granulosa cells might influence their vulnerability to apoptosis (Townson 
et al., 2010). Here, we demonstrated, for the first time, that granulosa cells 
are indeed more sensitive to Fas-induced apoptosis when K8/K18 filament 
expression is impaired. The reduction of K8/K18 filament expression in the 
granulosa cells was achieved using siRNA transfection, but similar effects 
have been observed in other types of non-ovarian epithelial cells in knockout 
mouse models or immortal cell lines (Caulin et al., 2000; Gilbert et al., 2001; 
Gilbert et al., 2004; Sullivan et al., 2010). In the K8 knockout mouse, for 
example, hepatocytes lacking K8/K18 filaments express more Fas on the cell 
surface, but also express less cFLIP, ERK1/2 and Akt intracellularly, which 
make them two times more sensitive to Fas-induced apoptosis than 
hepatocytes from wild-type mice. Essentially the K8/K18 filaments are 
thought to orchestrate the fate of epithelial cells by suppressing death 
signaling, while enhancing survival signals (Gilbert et al., 2001; Gilbert et al., 
2004). The K8/K18 filaments within granulosa cells of follicles might similarly 
dictate cellular fate, possibly by enabling the cells to evade Fas-induced 
apoptosis through similar mechanisms.
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The objectives of the current study were to determine the expression of 
K8/K18 filaments in granulosa cells, identify possible protective mechanisms 
by which granulosa cells resist apoptosis, and determine if K8/K18 filaments 
have a role in such protection. The results of this study support the concept 
that K8/K18 filaments influence granulosa cell fate, but whether they augment 
cFLIP expression and/or downstream survival signaling remains unclear.
Both KGN cells and primary cultures of bovine granulosa cells abundantly 
express K8/K18 filaments, and this abundance of filament expression was 
accompanied by a corresponding lack of Fas expression, at least in KGN 
cells. Whether or not these factors alone prevented Fas-induced apoptosis is 
uncertain, but our overall observations confirm those of previous studies. 
Namely, others have shown that cultured granulosa cells are extremely 
resistant to Fas-induced apoptosis (Quirk et al., 1998; Mezzanzanica et al., 
2004; Quirk et al., 2004; Matsuda et al., 2008). The current study also 
confirmed reports of others (Quirk et al., 1998; Matsuda et al., 2008) that 
cultured granulosa cells express labile protein(s), which in part provide 
protection against Fas-induced apoptosis. The cells are resistant to Fas- 
induced apoptosis unless pretreated with a protein synthesis inhibitor such as 
CHX (Quirk et al., 1998), or exposed to cytokines in combination with Fas 
ligand, such asTNF and IFN (Quirk etal., 1998; Porter etal., 2001). In the 
current work in which CHX augmented Fas-induced apoptosis, there was no 
effect of CHX on the anti-apoptotic protein, cFLIP, or the expression of total 
Fas as detected by immunoblot analysis. This implies that other labile
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survival protein(s), besides cFLIP and Fas, are expressed by granulosa cells 
to protect them from Fas-induced apoptosis.
Using KGN cells, we explored the possibility that signaling through 
MAPK and PI3K pathways (growth and stress activated pathways, 
respectively) might prevent Fas-induced apoptosis. Inhibition of the MAPK 
pathway, using the ERK1/2 inhibitor, had no clear effect on Fas-induced 
apoptosis. Surprisingly, inhibition of the PI3K pathway, using the Akt inhibitor, 
Wortmannin, actually enhanced the metabolic activity of the KGN cells, 
suggesting that although this pathway had no effect on Fas-induced 
apoptosis, other pathways affecting cellular metabolism become activated in 
response to Akt inhibition. Nevertheless, granulosa cell susceptibility to Fas- 
induced apoptosis is evidently not governed by the ERK1/2 or Akt pathways.
To determine overall whether K8/K18 filaments protect granulosa cells 
from Fas-induced apoptosis, the expression of the filaments was 
experimentally impaired using siRNA constructs. Knockdown of K8/K18 
expression was evident in both KGN cells and primary cultures of bovine 
granulosa cells, although the KGN cells required a higher concentration of 
siRNA to achieve measurable knockdown. These cells also appeared to be 
more tolerant of siRNA transfection than the primary cultures of bovine 
granulosa cells. For the bovine granulosa cells, the In-Cell Western assays 
revealed cytotoxicity effects, evident from lower cell density following KRT18 
siRNA transfection compared to those cells transfected with the non-targeting 
(i.e. scrambler) siRNA. Basal caspase activity (a measure of non-targeting
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siRNA -induced apoptosis) was also higher in the primary cultures of 
granulosa cells compared to KGN cell cultures. However, both the KGN cells 
and bovine granulosa cells became vulnerable to Fas-induced apoptosis 
following siRNA knockdown, providing the first evidence that K8/K18 
filaments influence granulosa cell resistance to apoptosis. The cellular 
mechanisms responsible for this protection (i.e., Fas reception and trafficking, 
activation of intracellular survival signals, etc.), however, remain unknown.
In conclusion, the abundance of K8/K18 intermediate filaments in 
granulosa cells provide a plausible cellular mechanism to prevent Fas- 
induced apoptosis, possibly by impairing Fas trafficking and/or activating 
downstream, intracellular survival signals. Here, we have provided evidence 
that labile protein(s), potentially associated with the K8/K18 filaments, provide 
resistance to apoptosis, while other downstream protective mechanisms await 
additional investigation. Similar mechanisms have been observed in 
epithelial cells of non-reproductive origin, notably hepatocytes (Gilbert et al., 
2001; Gilbert et al., 2004) and HeLa cells (Sullivan et al., 2010), suggesting 
the influence of cytoskeletal structure on Fas-induced apoptosis may be more 
universal than previously thought. In the context of the current work, the 
existence of K8/K18 filaments within granulosa cells of ovarian follicles have 
relevance to aspects of follicular atresia and the selection of follicles for 
ovulation. These insights have some bearing on therapeutic strategies that 
might enhance follicular growth and health within the ovary, thus leading to 
overall improvement in female fertility.
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